Driven by Science.Built for Clinical Clarity.

Enabling faster, scalable, and reliable analysis for clinical laboratories.

Our story

Intelliseq was created around a simple vision: genomic medicine can only reach its full potential when data interpretation becomes standardized, reproducible, and scalable.

Recognizing that the growing volume and complexity of genomic data was becoming a major barrier to clinical adoption, we set out to develop the technology that would transform raw sequencing data into reliable, actionable insights.

Today, we continue to build the infrastructure that enables clinical laboratories to scale genomic interpretation and bring the promise of precision medicine closer to everyday healthcare.

Our Mission

To accelerate precision medicine by turning genomic data into insight faster - where domain expertise, human judgement and automation meet in one scalable, interoperable platform.

Our values

Built on Real Expertise
Behind every pipeline we develop, is genuine domain knowledge. We don't just process genomic data - we understand it, across every indication we work in.
Driven by Understanding
Listening comes first. We take the time to truly understand each team's needs before we build - so what we deliver fits from day one.
Automate to Empower
We believe automation should complement human expertise, not compete with it. We handle the repetitive so teams can focus on what matters most - pairing the speed of automation with the depth of human insight.
Partners, not Customers
Every organisation we work with matters equally, whatever their size. We help labs grow - scaling with evolving needs while leaving the workflows they already rely on intact.

Meet the Leadership Team

A passionate leader and business development executive with a PhD in medical sciences. Focused on commercializing genetic products in collaboration with laboratories, clinicians, and researchers. MIT Enterprise Forum, Google for Startups, and US-Polish Trade Council alumni.
Klaudia Szklarczyk-Smolana, PhD
President of Board & CEO
Experienced bioinformatician with a great knowledge of implementations of novel algorithms and informatics methods into human genomics. Leader of R&D projects in the field of bioinformatics and computational genomics. R, Bash, and Python expert.
Marcin Piechota, PhD
CTO
20 years of experience in conducting research in the field of molecular biology and pharmacogenomics. Author of >100 scientific publications (H=32). Head of Laboratory of Pharmacogenomics, Maj Institute of Pharmacology PAS.
Michał Korostyński, PhD, DSc, MBA
Member of the Board of Directors and CSO
Strong business development professional with a PhD in biochemistry, focused on customer services and laboratory management at Intelliseq. Skilled in DNA and RNA next generation sequencing (NGS), molecular biology, neuroscience and oncology.
Sławomir Gołda, PhD
Board Member & CAO
Expert in biotech and pharma sales, combining data analysis with strategic growth initiatives. Background in cellular and molecular biology, skilled in translating complex science into market opportunities.
Mark Anthony Martinez
Vice President of Commercial
Molecular biologist with deep expertise in cancer genetics, working to bridge biology and technology to advance precision medicine. Supporting customers, leading product development in somatic cancer and utilizing big data to drive AI-powered healthcare solutions.
Klaudia Pacewicz
Head of Product
Bioinformatics and technology leader specializing in genomics, bioinformatics and machine learning, with expertise in cancer and rare-disease diagnostics. Combining computational biology and technology to advance precision medicine.
Paweł Sztromwasser, PhD
Head of Bioinformatics